Controlled drug release carriers based on PCL/PEO/PCL block copolymers
Source abstract
Abstract
In order to create a new drug delivery system, the ibuprofen-loaded triblock copolymer PCL/PEO/PCL (PCEC) microspheres with a low PEO content (<2 wt%) were prepared by oil in water (o/w) solvent evaporation technique. The influence of PEO content, molecular weight of a polymer matrix and drug loading on the ibuprofen release profiles were evaluated. The interactions between polymer matrix and ibuprofen were detected by FTIR analysis. The presence of hydrophilic PEO segment in PCL chains caused the decrease in particle size, which further had a great impact on the drug release kinetics, i.e., initially faster release and significantly higher quantity of released drug compared to neat PCL. Ibuprofen release behavior from polymer matrix was governed by a diffusion process. In vitro cytotoxicity tests revealed that empty PCL and PCEC microspheres were not toxic at low concentrations, while ibuprofen-loaded microspheres exhibited cytotoxicity correlated with amounts of incorporated drug.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems · Advanced Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia
Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia
Funding
Ministry of Education, Science and Technological Development of the Republic of Serbia
References (44)
Show source-provided references
1. 10.1007/3-540-45734-8_310.1007/3-540-45734-8_3 ↗
2. 10.1016/j.ijpharm.2004.01.04410.1016/j.ijpharm.2004.01.044 ↗
3. 10.1007/s10856-008-3581-410.1007/s10856-008-3581-4 ↗
4. 10.1016/0168-3659(94)00082-610.1016/0168-3659(94)00082-6 ↗
5. 10.1016/S0169-409X(99)00013-710.1016/S0169-409X(99)00013-7 ↗
6. 10.1016/S0168-3659(03)00367-510.1016/S0168-3659(03)00367-5 ↗
7. 10.1016/j.progpolymsci.2010.04.00210.1016/j.progpolymsci.2010.04.002 ↗
8. 10.1016/j.jconrel.2011.09.06410.1016/j.jconrel.2011.09.064 ↗
9. 10.1016/S0168-3659(01)00248-610.1016/S0168-3659(01)00248-6 ↗
10. 10.1016/S0169-409X(00)00136-810.1016/S0169-409X(00)00136-8 ↗
11. 10.1016/j.jmatprotec.2008.02.00410.1016/j.jmatprotec.2008.02.004 ↗
12. 10.1002/jps.1014310.1002/jps.10143 ↗
13. 10.1016/j.ijpharm.2009.07.03310.1016/j.ijpharm.2009.07.033 ↗
14. 10.1016/j.biomaterials.2004.04.00810.1016/j.biomaterials.2004.04.008 ↗
15. 10.1016/j.ijpharm.2008.03.02310.1016/j.ijpharm.2008.03.023 ↗
16. 10.1007/s00396-012-2768-x10.1007/s00396-012-2768-x ↗
17. 10.3923/jas.2009.2287.229310.3923/jas.2009.2287.2293 ↗
18. 10.1016/j.msec.2015.08.05810.1016/j.msec.2015.08.058 ↗
19. 10.1163/156856205441466710.1163/1568562054414667 ↗
20. 10.1016/j.ijpharm.2003.10.02910.1016/j.ijpharm.2003.10.029 ↗
21. 10.1016/j.ijpharm.2006.08.01910.1016/j.ijpharm.2006.08.019 ↗
22. 10.1007/s10924-017-1130-210.1007/s10924-017-1130-2 ↗
23. 10.1016/S0142-9612(03)00207-210.1016/S0142-9612(03)00207-2 ↗
24. 10.3109/02652048.2012.70495410.3109/02652048.2012.704954 ↗
25. 10.1007/s13233-016-4048-y10.1007/s13233-016-4048-y ↗
26. 10.1016/0022-1759(89)90397-910.1016/0022-1759(89)90397-9 ↗
27. 10.1016/S0168-3659(97)00081-310.1016/S0168-3659(97)00081-3 ↗
28. 10.1016/j.jconrel.2012.05.00310.1016/j.jconrel.2012.05.003 ↗
29. 10.1002/jps.2129710.1002/jps.21297 ↗
30. 10.1002/ddr.1039610.1002/ddr.10396 ↗
31. 10.1016/j.colsurfb.2005.04.01010.1016/j.colsurfb.2005.04.010 ↗
32. 10.1002/jbm.b.3136610.1002/jbm.b.31366 ↗
33. 10.1016/j.canlet.2011.08.00710.1016/j.canlet.2011.08.007 ↗
34. 10.1039/C2PY20686B10.1039/C2PY20686B ↗
35. 10.1016/j.ijpharm.2004.04.01310.1016/j.ijpharm.2004.04.013 ↗
36. 10.1016/0378-5173(94)90300-X10.1016/0378-5173(94)90300-X ↗
37. 10.1016/S0928-0987(01)00095-110.1016/S0928-0987(01)00095-1 ↗
38. 10.1016/S0168-3659(99)00253-910.1016/S0168-3659(99)00253-9 ↗
39. 10.1016/j.polymdegradstab.2012.05.03810.1016/j.polymdegradstab.2012.05.038 ↗
40. 10.1016/S0169-409X(01)00112-010.1016/S0169-409X(01)00112-0 ↗
41. Dash S. · Acta Pol. Pharm. · 2010 · 67 · 217
42. 10.1016/0168-3659(87)90035-610.1016/0168-3659(87)90035-6 ↗
43. 10.1016/0168-3659(87)90034-410.1016/0168-3659(87)90034-4 ↗
44. 10.1002/tox.2041010.1002/tox.20410 ↗